Integrated Services That Deliver Impactful Results
Generate actionable insights with our comprehensive suite of services and analytical expertise.
Committed support at every step of your therapeutic development journey
We understand that therapeutic development is not a series of discrete tasks – it’s a continuous, results-informed journey. Our end-to-end suite of services is designed to generate actionable, reproducible data anchored in real-world development insight. From first hypothesis to clinical implementation, we provide seamless, cross- functional support with a commitment to data integrity and operational excellence.
Advanced cell engineering, genomic manipulation and molecular profiling.
Services include:
- Cell line generation and authentication
- Cell expansion and banking
- Transfection and transduction
- RNAi knockdown (siRNA/shRNA)
- CRISPR/Cas9 and TALEN genome editing
- Site-directed mutagenesis
- Cloning (TOPO, recombination, ligation-based)
- Mycoplasma and sterility testing
- Nucleic acid purification from any biological matrix
- Gene expression analysis (qRT-PCR, dPCR, NGS)
- Sanger and next-generation sequencing (NGS)
Custom and high-throughput assays for functional validation and screening.
Services include:
- Apoptosis and necrosis assays
- Viability and cytotoxicity assays
- Reporter gene assays
- Enzymology
- Signal transduction and kinase assays
- Metabolism and cellular bioenergetics assays
- Protein-protein interaction assays
- Compound screening (96- and 384-well formats)
- Access to 100K pharmaceutically active compound library
- Custom assay development and execution
Complete support for recombinant protein production and functional analysis.
Services include:
- Protein expression using bacterial, mammalian, and baculovirus systems
- Protein purification and yield optimization
- Functional protein assays (enzymology, binding and interaction)
Comprehensive histology and imaging to map tissue-level expression.
Services include:
- Trimming, processing, and embedding of fixed and frozen tissue
- Serial and step sectioning
- Histological staining
- Immunohistochemistry (IHC) – including method development
- Immunofluorescence (IF) – including method development
- In situ hybridization (ISH)
- Fluorescence in situ hybridization (FISH)
- Digital pathology and quantitative image analysis
COLA-accredited and CLIA-certified testing and biomarker analysis across multiple matrices.
Services include:
- Analysis of urine, serum, blood, and plasma
- BUN, creatinine, albumin
- Fasting blood glucose (FBG), HbA1c, fructose
- ALT, AST, ALP, uric acid, total cholesterol
- Custom Lab-Developed Tests (LDTs) under CLIA certification
Strategic guidance and cross-functional integration.
We actively support your program from study design through interpretation and planning next steps. Whether you’re optimizing a screening assay, validating a preclinical biomarker or preparing a diagnostic for clinical deployment, we act as a scientific extension of your internal team – ensuring quality, context and alignment at every step.